vimarsana.com

Page 3 - ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் ஜென்னர் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Malaria s big lesson for Covid-19 pandemic: get ready for a long battle

news Malaria’s big lesson for coronavirus pandemic: get ready for a long battle Medical volunteers from the Doctors Without Borders (MSF) organisation visit people during a vaccination day in Barcelona, Anzoategui state, Venezuela, on March 16. In Venezuela, there are people who have had malaria up to 20 times. Photo: AFP Drowned out and distracted by the noise and enormous numbers from the Covid-19 pandemic, in particular the gruesome spectacle of funeral pyres burning across the length and breadth of India, you could be excused for taking your eye off the numerous other diseases that threaten us worldwide. Unless, of course, you suffer from one of them, in which case, wherever you live, you have faced treatment cancellations, disruption of transport services to and from hospitals or clinics, medical supply shortages, and expert medical staff reassigned.

How much money is AstraZeneca making from its Covid vaccine? — Quartz

April 30, 2021 In an upbeat earnings report today (April 30), Anglo-Swedish drugmaker AstraZeneca reported $275 million in revenue from its Covid-19 vaccine in the first three months of the year. The vaccine, known as Vaxzevria, is one of four authorized for use against Covid-19 in the EU. It’s also been one of the more controversial ones: Many countries paused their rollout of the jab when it emerged that it can, in some rare cases, cause blood clots. AstraZeneca has also become embroiled in a public showdown with the EU over delayed supplies; the bloc is suing the company for alleged breach of contract. Meanwhile, the US has not approved the shot and plans to send most of its supply overseas.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.